Analyst Research Roundup: The Southern Company (SO), Seattle Genetics, Inc. (SGEN)

Lloyd Doyle
October 12, 2017

Parametric Portfolio Associates LLC now owns 114,097 shares of the biotechnology company's stock worth $7,172,000 after purchasing an additional 24,641 shares during the period. The stock rose 0.03% or $0.02 reaching $65.03. About 5,116 shares traded. Moody's Corporation (MCO) has risen 23.29% since October 12, 2016 and is uptrending. It has underperformed by 4.78% the S&P500. The company's net profit margin has achieved the current level of 2.8 percent and possesses 87.9 percent gross margin. Spark Investment Management Llc bought 86,900 shares as the company's stock rose 1.68% with the market. Shares are now up over the past year, outperforming the broad market by -100% and outperformed a peer group of similar companies by 20%. The stock declined 0.14% or $0.07 reaching $48.79 on the news. About 703,181 shares traded. Seattle Genetics, Inc. (NASDAQ:SGEN) has risen 75.68% since October 11, 2016 and is uptrending. It has outperformed by 58.98% the S&P500.

Wall Street brokerage firms that regularly cover the stock have provided price targets and recommendations on Seattle Genetics, Inc. Therefore 38% are positive. Finally, Royal Bank Of Canada initiated coverage on Seattle Genetics in a report on Thursday, September 14th. As per Tuesday, January 3, the company rating was maintained by Barclays Capital. The firm set a "hold" rating on the biotechnology company's stock. The firm has "Buy" rating by Jefferies given on Monday, June 12. Lpl Financial Llc invested 0% of its portfolio in Seattle Genetics, Inc. (NASDAQ:SGEN) in a research report sent to investors on Tuesday morning. On Tuesday, August 25 the stock rating was maintained by William Blair with "Buy". The company was maintained on Wednesday, August 30 by RBC Capital Markets. Florida-based Carl Domino has invested 0.31% in Seattle Genetics, Inc. The rating was downgraded by Credit Suisse on Monday, December 12 to "Neutral".

Seattle Genetics (NASDAQ:SGEN) last announced its quarterly earnings data on Thursday, July 27th.

The latest exchange of 0.44 Million shares is below its average trading activity of 989.81 Million shares. Vaughn B. Himes, CTO sold $530,900 worth of shares at an average price of $53.09 on Friday the 8th. The recent change has given its price a 19.55% lead over SMA 50 and -18.43% deficit over its 52-week high. (NASDAQ:SGEN)'s stock is experiencing unusual volume during today's trading. Finally, Janus Capital Management LLC increased its holdings in Seattle Genetics by 321.2% in the first quarter.

Seattle Genetics, Inc is a biotechnology company focused on the development and commercialization of therapies for the treatment of cancer.

Investors sentiment decreased to 1.3 in 2017 Q2. Analysts rating the company a 1 or 2 indicate a Buy recommendation. Georgia-based Emory University has invested 1.08% in Seattle Genetics, Inc. (NASDAQ:SGEN). Dekabank Deutsche Girozentrale stated it has 0.04% of its portfolio in Seattle Genetics, Inc. (NASDAQ:SGEN)'s stock about 4.71% from the 50-day high and 36.42% away from the 50-day low. BidaskClub cut Seattle Genetics from a "sell" rating to a "strong sell" rating in a research note on Wednesday, August 2nd. (NASDAQ:SGEN). 4,818 are owned by Sterling Cap Ltd Com.


Several hedge funds and other institutional investors have recently added to or reduced their stakes in SGEN. Moreover, Fmr Limited Liability Corporation has 0.05% invested in Seattle Genetics, Inc. (NASDAQ:SGEN) for 106,700 shares. Company insiders own 34.70% of the company's stock. Capstone Asset Mgmt reported 5,035 shares or 0.01% of all its holdings. Credit Agricole S A accumulated 0% or 16,395 shares. Oppenheimer Asset Management Incorporated holds 0% or 1,511 shares in its portfolio. (NASDAQ:SGEN) to report earnings on October, 26. During the same period in the prior year, the firm earned ($0.23) earnings per share. Three research analysts have rated the stock with a sell rating, twelve have issued a hold rating, eight have issued a buy rating and one has assigned a strong buy rating to the company's stock. Therefore 67% are positive. Verizon Communications Inc. had 51 analyst reports since July 22, 2015 according to SRatingsIntel. SunTrust upgraded the stock to "Buy" rating in Monday, July 31 report. The firm has "Market Perform" rating by Avondale given on Wednesday, October 21. The rating was maintained by J.P. Morgan with "Hold" on Thursday, June 8. The company was maintained on Friday, September 15 by Needham. Robert W. Baird has "Hold" rating and $49.0 target. On Monday, June 26 the stock rating was maintained by Cowen & Co with "Hold".

Another recent and important ICON PLC (NASDAQ:ICLR) news was published by Streetinsider.com which published an article titled: "BofA/Merrill Lynch Starts ICON plc (ICLR) at Buy" on September 11, 2017. After this sale, 77,230 common shares of SGEN are directly owned by the insider, with total stake valued at $4,747,328.

Since May 31, 2017, it had 0 insider purchases, and 5 sales for $3.61 million activity.

Investors sentiment decreased to 0.88 in Q2 2017. Its up 0.01, from 0.9 in 2017Q1. It worsened, as 85 investors sold GE shares while 816 reduced holdings. 72 funds opened positions while 123 raised stakes. Appleton Prns Inc Ma has invested 0.1% of its portfolio in Altria Group Inc (NYSE:MO). (NYSE:VZ). The Texas-based Sentinel Trust Lba has invested 0.47% in Verizon Communications Inc. Joel Isaacson And Lc invested in 0.76% or 149,317 shares. Oakworth Capital owns 49,282 shares or 0.36% of their USA portfolio. (NYSE:VZ). Selway Asset Mgmt invested in 46,871 shares. Live Your Vision Limited Liability Company holds 0.08% or 4,301 shares. Family Mngmt has invested 3.17% in Verizon Communications Inc. Primecap Mngmt Ca, a California-based fund reported 171,300 shares. Gamco Et Al stated it has 69,850 shares. Allsquare Wealth Mgmt Ltd Liability Corp holds 139 shares. Virginia-based Vnbtrust Association has invested 0.16% in Verizon Communications Inc. Old Natl Bank In has 0.24% invested in Altria Group Inc (NYSE:MO) for 58,251 shares.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Other reports by Iphone Fresh

Discuss This Article

FOLLOW OUR NEWSPAPER